THOMASVILLE- The urologists at Archbold Urology recently performed a cutting-edge procedure that was the first of its kind in South Georgia.
The procedure is known as a holmium laser enucleation of the prostate (HoLEP) and is used to treat benign prostatic hyperplasia or BPH. This procedure is the latest innovation in urologic laser technology.
BPH is a noncancerous enlargement of the prostate gland, commonly known as an enlarged prostate. It is the most common type of benign tumor found in men.
“BPH becomes more common as men age because the prostate often gets bigger as you get older,” said Eric Webb, MD, urologist at Archbold Urology. “BPH can cause bladder, urinary tract or kidney problems, but the main symptom is weak stream that can greatly affect a patient’s quality of life. It’s the main reason most men seek treatment.”
The HoLEP procedure is a significant evolution in the treatment of BPH, providing significantly improved outcomes for a majority of patients regardless of prostate size, anticoagulant therapy, and age. More than 90% of patients are able to return home the day of the procedure, and less than 1% require an additional operation.
“We always strive to offer our patients and community the best care possible by staying abreast of new technologies and by treating each patient with the compassion they deserve,” said Jason Burnette, MD, urologist at Archbold Urology.
“This HoLEP procedure is reflective of Archbold’s mission to provide innovative care to our communities, and it demonstrates our continued investment in minimally invasive treatment options for the people of South Georgia,” said Brock Dockery, Assistant Vice President of Archbold Medical Group.
Those in need of routine and complex urological treatment may call Archbold Urology at 229.228.5500 to schedule an appointment or visit www.archbold.org/urology to learn more.